Members of a new class of antivirals are being tested in U.S. clinical trials, and one has gained approval in Japan, but how ...
CAMBRIDGE, United Kingdom and NEW YORK, October 13, 2025 – Artios Pharma Limited (“Artios”), a biopharmaceutical company committed to realizing the therapeutic power of targeting the DNA damage ...
News Medical on MSN
A new study reveals how cholera virulence is activated
CSIC, reveals how the bacterium that causes cholera activates its virulence programme, uncovering a single amino acid as a ...
A medical breakthrough could result in the first treatment for rare but serious diseases in which genetic defects disrupt cellular energy production. Researchers at the University of Gothenburg have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback